Clinical trial
A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease
NCT01494428 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease
- Lead sponsor
- Medtronic Spinal and Biologics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 1998
- Completion date
- February 29, 2004
- Enrollment
- 46 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative disc disease